The Investigators aim to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. The Investigators will administer speech tasks and cognitive assessments to participants with Parkinson's disease and healthy controls. The Investigators will also explore the associations between genetic factors and speech and cognitive status in Parkinson's disease.
Study Type
OBSERVATIONAL
Enrollment
58
Participants will be asked to complete a series of cognitive testing (testing of concentration, memory, and other thinking abilities).
Participants will be asked to perform speaking and reading tasks, which will be recorded. Participants will be asked to complete a laptop-based test of language comprehension.
Participants with Parkinson's disease will complete an examination of their symptoms and questionnaires assessing disease symptoms, mood and activities of daily living. Healthy controls participants will be asked to complete questionnaires on mood.
UMass Medical School/UMass Memorial Medical Center
Worcester, Massachusetts, United States
Mild Cognitive Impairment
Mild cognitive impairment classified by Movement Disorders Society Task Force Level II Critieria
Time frame: baseline
Mean Fundamental Frequency
These acoustic measures during spontaneous speech (picture description) were calculated using Praat
Time frame: baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Participants will have their blood drawn for DNA analysis.